Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| DB Dash BioCompany profile Automated bioanalysis platform delivering faster preclinical and clinical drug test results Automated bioanalysis platform delivering faster preclinical and clinical drug test results | $30M | Series A | Biotech | United States | Investors | |
| RT Developing best-in-class radiopharmaceuticals for cancer treatment |
Ranked by rounds participated in · All time
AusperBio, Abcuro, Infinimmune
Epicrispr Biotechnologies, Draig Therapeutics, Triveni Bio
LifeMine Therapeutics, Ollin Biosciences, SonoThera
Leal Therapeutics, Khartis Therapeutics, Vedana Therapeutics
Leal Therapeutics, Amplifica Holdings Group, InduPro
Explore published rounds while the next edition is being prepared.
| $70M |
| Series CSeries C+ |
| Biotech |
| United States |
| Investors |
| AT Adjuvia TherapeuticsCompany profile Developing therapeutics to treat mitochondrial dysfunction and disease Developing therapeutics to treat mitochondrial dysfunction and disease | $8M | Seed | Biotech | United States | Investors |
| TB Developing nerve-targeted imaging technologies for surgery. | Undisclosed | Series A | Biotech | United States | Investors |
| CB CORE BiomedicineCompany profile Developing the next generation of precision medicines by going beyond genomics. Developing the next generation of precision medicines by going beyond genomics. | $21M | Series A | Biotech | United States | Investors |
| TP Torrey Pines MedicineCompany profile Develops ultra-long-acting peptide therapeutics for obesity, diabetes, and metabolic diseases Develops ultra-long-acting peptide therapeutics for obesity, diabetes, and metabolic diseases | Undisclosed | Pre-SeedPre-seed | Biotech | China | Investors |
| VD Vivid DxCompany profile Rapid infectious disease testing helping hospitals identify pathogens and guide antibiotic decisions Rapid infectious disease testing helping hospitals identify pathogens and guide antibiotic decisions | $15M | Seed | Biotech, Healthtech | United Kingdom | Investors |
| M MiraeCompany profile AI-driven continuous care platform for autoimmune disease and other complex chronic conditions AI-driven continuous care platform for autoimmune disease and other complex chronic conditions | $5.4M | Seed | Biotech, Healthtech | United Kingdom | Investors |
| MT Moa TechnologyCompany profile An agricultural biotechnology company focused on discovering novel mode of action herbicides An agricultural biotechnology company focused on discovering novel mode of action herbicides | £22.2M | Series CSeries C+ | Biotech, Agritech | United Kingdom | Investors |
| TA Tikva AllocellCompany profile Developing engineered, allogeneic (donor-derived) cell therapies for adult and pediatric patients with solid tumors Developing engineered, allogeneic (donor-derived) cell therapies for adult and pediatric patients with solid tumors | $8M | Series A | Biotech | Singapore | Investors |